{"id":"https://openalex.org/W140465258","doi":"https://doi.org/10.1182/blood.v84.9.3142.3142","title":"Altered levels of interleukin-1 beta and interleukin-1 receptor antagonist in chronic myelogenous leukemia: clinical and prognostic correlates","display_name":"Altered levels of interleukin-1 beta and interleukin-1 receptor antagonist in chronic myelogenous leukemia: clinical and prognostic correlates","publication_year":1994,"publication_date":"1994-11-01","ids":{"openalex":"https://openalex.org/W140465258","doi":"https://doi.org/10.1182/blood.v84.9.3142.3142","mag":"140465258","pmid":"https://pubmed.ncbi.nlm.nih.gov/7949186"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v84.9.3142.3142","doi":"https://doi.org/10.1182/blood.v84.9.3142.3142","is_oa":true,"landing_page_url":"https://doi.org/10.1182/blood.v84.9.3142.3142","pdf_url":"https://ashpublications.org/blood/article-pdf/84/9/3142/618615/3142.pdf","source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://ashpublications.org/blood/article-pdf/84/9/3142/618615/3142.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5039028985","display_name":"Meir Wetzler","orcid":"https://orcid.org/0000-0003-1397-5942","observed_orcids":["https://orcid.org/0000-0003-1397-5942"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M Wetzler","raw_affiliation_strings":["Department of Clinical Investigation, University of Texas M.D. Anderson Cancer Center, Houston"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Investigation, University of Texas M.D. Anderson Cancer Center, Houston","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053481267","display_name":"Razelle Kurzrock","orcid":"https://orcid.org/0000-0003-4110-1214","observed_orcids":["https://orcid.org/0000-0003-4110-1214"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R Kurzrock","raw_affiliation_strings":["Department of Clinical Investigation, University of Texas M.D. Anderson Cancer Center, Houston"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Investigation, University of Texas M.D. Anderson Cancer Center, Houston","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084290698","display_name":"Zeev E. Estrov","orcid":"https://orcid.org/0000-0002-1623-3613","observed_orcids":["https://orcid.org/0000-0002-1623-3613"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Z Estrov","raw_affiliation_strings":["Department of Clinical Investigation, University of Texas M.D. Anderson Cancer Center, Houston"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Investigation, University of Texas M.D. Anderson Cancer Center, Houston","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090435894","display_name":"Hagop M. Kantarjian","orcid":"https://orcid.org/0000-0002-1908-3307","observed_orcids":["https://orcid.org/0000-0002-1908-3307"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"H Kantarjian","raw_affiliation_strings":["Department of Clinical Investigation, University of Texas M.D. Anderson Cancer Center, Houston"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Investigation, University of Texas M.D. Anderson Cancer Center, Houston","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049331182","display_name":"Heinz Gisslinger","orcid":"https://orcid.org/0000-0002-0295-7629","observed_orcids":["https://orcid.org/0000-0002-0295-7629"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"H Gisslinger","raw_affiliation_strings":["Department of Clinical Investigation, University of Texas M.D. Anderson Cancer Center, Houston"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Investigation, University of Texas M.D. Anderson Cancer Center, Houston","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022309641","display_name":"MP Underbrink","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"MP Underbrink","raw_affiliation_strings":["Department of Clinical Investigation, University of Texas M.D. Anderson Cancer Center, Houston"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Investigation, University of Texas M.D. Anderson Cancer Center, Houston","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5011529063","display_name":"Moshe Talpaz","orcid":"https://orcid.org/0000-0003-3361-3981","observed_orcids":["https://orcid.org/0000-0003-3361-3981"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M Talpaz","raw_affiliation_strings":["Department of Clinical Investigation, University of Texas M.D. Anderson Cancer Center, Houston"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Investigation, University of Texas M.D. Anderson Cancer Center, Houston","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1343551460"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":1.1286,"has_fulltext":true,"cited_by_count":70,"citation_normalized_percentile":{"value":0.76402203,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"84","issue":"9","first_page":"3142","last_page":"3147"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.9765999913215637,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.9765999913215637,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.003000000026077032,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0024999999441206455,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chronic-myeloid-leukemia","display_name":"chronic myeloid leukemia","score":0.9440000057220459},{"id":"https://openalex.org/keywords/interleukin-1beta","display_name":"IL-1\u03b2","score":0.9990000128746033},{"id":"https://openalex.org/keywords/interleukin-1-receptor-antagonist","display_name":"interleukin-1 receptor antagonist","score":0.9990000128746033},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.7369999885559082},{"id":"https://openalex.org/keywords/survival","display_name":"survival","score":0.7519999742507935},{"id":"https://openalex.org/keywords/accelerated-phase","display_name":"accelerated phase","score":0.8050000071525574},{"id":"https://openalex.org/keywords/blast-crisis","display_name":"blast crisis","score":0.7850000262260437},{"id":"https://openalex.org/keywords/il-1-inhibitors","display_name":"IL-1 inhibitors","score":0.6259999871253967},{"id":"https://openalex.org/keywords/disease-progression","display_name":"disease progression","score":0.45399999618530273},{"id":"https://openalex.org/keywords/bone-marrow-blasts","display_name":"bone marrow blasts","score":0.5709999799728394},{"id":"https://openalex.org/keywords/cytokine-bioactivity","display_name":"cytokine bioactivity","score":0.5400000214576721},{"id":"https://openalex.org/keywords/chronic-phase","display_name":"chronic phase","score":0.41499999165534973},{"id":"https://openalex.org/keywords/philadelphia-chromosome-positive-leukemia","display_name":"Philadelphia chromosome-positive leukemia","score":0.7089999914169312},{"id":"https://openalex.org/keywords/prognostic-scoring","display_name":"prognostic scoring","score":0.3970000147819519}],"concepts":[{"id":"https://openalex.org/C2776960273","wikidata":"https://www.wikidata.org/wiki/Q729735","display_name":"Chronic myelogenous leukemia","level":3,"score":0.6185360550880432},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.551650881767273},{"id":"https://openalex.org/C2776174256","wikidata":"https://www.wikidata.org/wiki/Q830842","display_name":"BETA (programming language)","level":2,"score":0.5346856117248535},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4766966998577118},{"id":"https://openalex.org/C74172505","wikidata":"https://www.wikidata.org/wiki/Q194908","display_name":"Interleukin","level":3,"score":0.4504354000091553},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.4449917674064636},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.44323208928108215},{"id":"https://openalex.org/C149892131","wikidata":"https://www.wikidata.org/wiki/Q14914156","display_name":"Interleukin 1 receptor antagonist","level":5,"score":0.4426729679107666},{"id":"https://openalex.org/C117262875","wikidata":"https://www.wikidata.org/wiki/Q5135057","display_name":"Clonogenic assay","level":3,"score":0.43972504138946533},{"id":"https://openalex.org/C2777371288","wikidata":"https://www.wikidata.org/wiki/Q410130","display_name":"Interleukin 2","level":3,"score":0.43016138672828674},{"id":"https://openalex.org/C2778122271","wikidata":"https://www.wikidata.org/wiki/Q410943","display_name":"Receptor antagonist","level":4,"score":0.42376238107681274},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.42176416516304016},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.3919069766998291},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3622143268585205},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3318634629249573},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.263162761926651},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.20382359623908997},{"id":"https://openalex.org/C199360897","wikidata":"https://www.wikidata.org/wiki/Q9143","display_name":"Programming language","level":1,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D001853","descriptor_name":"Bone Marrow","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007375","descriptor_name":"Interleukin-1","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012795","descriptor_name":"Sialoglycoproteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D015464","descriptor_name":"Leukemia, Myelogenous, Chronic, BCR-ABL Positive","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D015464","descriptor_name":"Leukemia, Myelogenous, Chronic, BCR-ABL Positive","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D016019","descriptor_name":"Survival Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053590","descriptor_name":"Interleukin 1 Receptor Antagonist Protein","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1182/blood.v84.9.3142.3142","doi":"https://doi.org/10.1182/blood.v84.9.3142.3142","is_oa":true,"landing_page_url":"https://doi.org/10.1182/blood.v84.9.3142.3142","pdf_url":"https://ashpublications.org/blood/article-pdf/84/9/3142/618615/3142.pdf","source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},{"id":"doi:10.1182/blood.v84.9.3142.bloodjournal8493142","doi":"https://doi.org/10.1182/blood.v84.9.3142.bloodjournal8493142","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v84.9.3142.bloodjournal8493142","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},{"id":"pmid:7949186","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7949186","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"Clinical Trial"}],"best_oa_location":{"id":"doi:10.1182/blood.v84.9.3142.3142","doi":"https://doi.org/10.1182/blood.v84.9.3142.3142","is_oa":true,"landing_page_url":"https://doi.org/10.1182/blood.v84.9.3142.3142","pdf_url":"https://ashpublications.org/blood/article-pdf/84/9/3142/618615/3142.pdf","source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W140465258.pdf","grobid_xml":"https://content.openalex.org/works/W140465258.grobid-xml"},"referenced_works_count":35,"referenced_works":["https://openalex.org/W236534077","https://openalex.org/W341725904","https://openalex.org/W1520575618","https://openalex.org/W1532410262","https://openalex.org/W1574330564","https://openalex.org/W1576398733","https://openalex.org/W1689083412","https://openalex.org/W1979300931","https://openalex.org/W1989459539","https://openalex.org/W2007000374","https://openalex.org/W2039008259","https://openalex.org/W2058554371","https://openalex.org/W2069486259","https://openalex.org/W2073598149","https://openalex.org/W2078483536","https://openalex.org/W2088134165","https://openalex.org/W2089697181","https://openalex.org/W2094607755","https://openalex.org/W2097457224","https://openalex.org/W2143594378","https://openalex.org/W2144165008","https://openalex.org/W2165421077","https://openalex.org/W2276472705","https://openalex.org/W2307732956","https://openalex.org/W2332739634","https://openalex.org/W2395259494","https://openalex.org/W2405878472","https://openalex.org/W2407484150","https://openalex.org/W2410684636","https://openalex.org/W2410870472","https://openalex.org/W2413037117","https://openalex.org/W2418638740","https://openalex.org/W2435047752","https://openalex.org/W3098834126","https://openalex.org/W4293241248"],"related_works":["https://openalex.org/W236534077","https://openalex.org/W2589068114","https://openalex.org/W2005786547","https://openalex.org/W2128224354","https://openalex.org/W7098853670","https://openalex.org/W2062936595","https://openalex.org/W1964269814","https://openalex.org/W1967403622","https://openalex.org/W2093766370","https://openalex.org/W3029128865"],"abstract_inverted_index":{"We":[0],"have":[1],"recently":[2],"demonstrated":[3,145],"that":[4,18,198,228,264],"interleukin":[5],"(IL)-1":[6],"beta":[7,35,42,64,93,141,163,192,205,222,230,267,329,344],"levels":[8,48,164,177,193,206,231,268,286,315,347],"are":[9],"elevated":[10,161,190],"in":[11,37,49,95,120,235,237,252,273,348],"advanced":[12],"chronic":[13,253],"myelogenous":[14],"leukemia":[15],"(CML)":[16],"and":[17,43,58,65,86,223,263,276,299,345],"IL-1":[19,34,41,44,63,92,140,162,191,204,221,229,266,328,343],"inhibitors":[20],"can":[21],"suppress":[22],"CML":[23,56,98,224,292,350],"clonogenic":[24],"growth.":[25],"To":[26],"further":[27],"assess":[28],"the":[29,75,81,96,117,170,186,242,274],"clinical":[30],"implications":[31],"of":[32,55,78,80,175,185,199,241,316],"increased":[33,271],"expression":[36],"CML,":[38],"we":[39],"analyzed":[40],"receptor":[45],"antagonist":[46],"(IL-1RA)":[47],"leukocyte":[50],"lysates":[51],"from":[52,59],"a":[53,147,153],"series":[54],"patients":[57,99,188,236,251,293,307],"normal":[60,176],"volunteers.":[61],"Both":[62],"IL-1RA":[66,285,317,336,346],"were":[67,165,232],"measured":[68],"by":[69,215],"enzyme-linked":[70],"immunosorbent":[71],"assays":[72,82],"(ELISAs),":[73],"with":[74,146,189,250,270,308],"lower":[76,314],"limits":[77],"sensitivity":[79],"being":[83],"20":[84],"pg/mL":[85],"6.5":[87],"pg/mL,":[88],"respectively.":[89],"The":[90,183],"median":[91,118],"level":[94,119],"81":[97],"tested":[100],"was":[101,142,194,339],"higher":[102,234],"(115.8":[103],"pg/2.4":[104,112,125,133,179,245,256,296,304,320],"x":[105,113,126,134,180,246,257,297,305,321],"10(7)":[106,114,127,135,181,247,258],"cells;":[107,128],"range,":[108,129],"0":[109,130],"to":[110,131,152,334],"2,000":[111],"cells)":[115,136,248,259],"than":[116,197],"25":[121],"control":[122],"samples":[123],"(10.8":[124],"95.5":[132],"(P":[137,260,279],"<":[138,261,280],".01).":[139,281],"bioactive,":[143],"as":[144,167],"bioassay":[148],"based":[149],"on":[150],"cytotoxicity":[151],"melanoma":[154],"cell":[155],"line":[156],"(A375).":[157],"For":[158],"survival":[159,184],"analysis,":[160],"defined":[166],"those":[168,200],"exceeding":[169],"mean":[171],"+":[172],"2":[173],"SD":[174],"(83":[178],"cells).":[182],"44":[187,208],"significantly":[195,233,313],"shorter":[196],"who":[201],"had":[202,312],"low":[203],"(median,":[207,294,302,318],"v":[209],"58":[210],"months;":[211],"P":[212,323],"=":[213,324],".049":[214],"Wilcoxon-Gehan":[216],"method).":[217],"An":[218],"association":[219],"between":[220,290,342],"prognostic":[225],"criteria":[226],"shows":[227],"accelerated/blastic":[238],"crisis":[239,310],"phases":[240],"disease":[243,311],"(364.0":[244],"compared":[249],"phase":[254],"(102.0":[255],".01),":[262],"high":[265],"correlated":[269],"blasts":[272],"marrow":[275],"peripheral":[277],"blood":[278],"In":[282],"contrast,":[283],"while":[284],"did":[287],"not":[288],"differ":[289],"chronic-phase":[291],"471.7":[295],"10(5))":[298],"healthy":[300],"volunteers":[301],"454.4":[303],"10(5)),":[306],"accelerated/blast":[309],"218.7":[319],"10(5);":[322],".03).":[325],"Finally,":[326],"although":[327],"has":[330],"been":[331],"previously":[332],"shown":[333],"increase":[335],"levels,":[337],"there":[338],"no":[340],"correlation":[341],"our":[349],"patients.(ABSTRACT":[351],"TRUNCATED":[352],"AT":[353],"400":[354],"WORDS)":[355]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":7},{"year":2022,"cited_by_count":2},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}